Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to ...

Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Waiting times of up to five years for specialist treatment driving patients to purchase drugs from unregulated retailers ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

Prof Kamila Hawthorne, chairwoman of the Royal College of GPs, warned people are putting themselves at risk by buying ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.